IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
- PMID: 16286016
- DOI: 10.1016/j.immuni.2005.09.015
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
Abstract
Cytokines of the interleukin-1 (IL-1) family, such as IL-1 alpha/beta and IL-18, have important functions in host defense, immune regulation, and inflammation. Insight into their biological functions has led to novel therapeutic approaches to treat human inflammatory diseases. Within the IL-1 family, IL-1 alpha/beta, IL-1Ra, and IL-18 have been matched to their respective receptor complexes and have been shown to have distinct biological functions. The most prominent orphan IL-1 receptor is ST 2. This receptor has been described as a negative regulator of Toll-like receptor-IL-1 receptor signaling, but it also functions as an important effector molecule of T helper type 2 responses. We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST 2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokines from in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.
Similar articles
-
Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.J Biol Chem. 2002 Dec 20;277(51):49205-11. doi: 10.1074/jbc.M209685200. Epub 2002 Oct 3. J Biol Chem. 2002. PMID: 12368275
-
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.Int Immunol. 2008 Aug;20(8):1019-30. doi: 10.1093/intimm/dxn060. Epub 2008 Jun 11. Int Immunol. 2008. PMID: 18550585
-
Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.Allergy. 2014 Jun;69(6):719-29. doi: 10.1111/all.12388. Epub 2014 Apr 15. Allergy. 2014. PMID: 24735452
-
New dog and new tricks: evolving roles for IL-33 in type 2 immunity.J Leukoc Biol. 2015 Jun;97(6):1037-48. doi: 10.1189/jlb.3RI1214-595R. Epub 2015 Mar 23. J Leukoc Biol. 2015. PMID: 25801770 Review.
-
IL-33 and IL-33 receptors in host defense and diseases.Allergol Int. 2010 Jun;59(2):143-60. doi: 10.2332/allergolint.10-RAI-0186. Epub 2010 Apr 24. Allergol Int. 2010. PMID: 20414050 Review.
Cited by
-
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine.Front Cell Dev Biol. 2020 Aug 21;8:737. doi: 10.3389/fcell.2020.00737. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32974331 Free PMC article. Review.
-
B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.Front Cell Dev Biol. 2022 Sep 23;10:991840. doi: 10.3389/fcell.2022.991840. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36211467 Free PMC article. Review.
-
Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.J Leukoc Biol. 2016 Dec;100(6):1395-1404. doi: 10.1189/jlb.3A0316-125R. Epub 2016 Jul 21. J Leukoc Biol. 2016. PMID: 27443878 Free PMC article.
-
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages.J Exp Med. 2013 Mar 11;210(3):535-49. doi: 10.1084/jem.20121964. Epub 2013 Feb 18. J Exp Med. 2013. PMID: 23420878 Free PMC article.
-
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.J Allergy Clin Immunol. 2015 Sep;136(3):747-756.e4. doi: 10.1016/j.jaci.2015.03.011. Epub 2015 Apr 28. J Allergy Clin Immunol. 2015. PMID: 25930197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
